LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 17 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) |
Relevant securities | ||||
1,748,955 |
1.36% |
233,388 |
0.18% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
72,359 |
0.06% |
94,581 |
0.07% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 |
0.00% |
6,100 |
0.00% |
|
|
|
|
|
||
TOTAL: |
|
|
|
|
|
1,827,414 |
1.42% |
334,069 |
0.26% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase |
1 |
233.5700 USD |
Purchase |
2 |
236.5200 USD |
Purchase |
2 |
235.3920 USD |
Purchase |
3 |
234.2200 USD |
Purchase |
18 |
233.6700 USD |
Purchase |
23 |
232.6300 USD |
Purchase |
24 |
232.7025 USD |
Purchase |
61 |
238.4673 USD |
Purchase |
98 |
232.9100 USD |
Purchase |
100 |
232.2900 USD |
Purchase |
100 |
233.4500 USD |
Purchase |
100 |
233.6400 USD |
Purchase |
100 |
232.3000 USD |
Purchase |
100 |
233.9600 USD |
Purchase |
128 |
232.9131 USD |
Purchase |
134 |
234.9476 USD |
Purchase |
145 |
233.2227 USD |
Purchase |
149 |
231.7638 USD |
Purchase |
178 |
232.7797 USD |
Purchase |
216 |
237.8386 USD |
Purchase |
227 |
235.0653 USD |
Purchase |
300 |
233.2900 USD |
Purchase |
375 |
231.7200 USD |
Purchase |
402 |
233.0244 USD |
Purchase |
465 |
234.9607 USD |
Purchase |
600 |
237.3350 USD |
Purchase |
600 |
237.7416 USD |
Purchase |
606 |
236.8871 USD |
Purchase |
634 |
233.8520 USD |
Purchase |
640 |
233.2741 USD |
Purchase |
720 |
236.6315 USD |
Purchase |
729 |
236.2395 USD |
Purchase |
891 |
232.9654 USD |
Purchase |
917 |
234.9315 USD |
Purchase |
1,150 |
236.8537 USD |
Purchase |
1,253 |
233.7280 USD |
Purchase |
1,421 |
234.3096 USD |
Purchase |
1,475 |
235.2884 USD |
Purchase |
1,557 |
233.1962 USD |
Purchase |
1,700 |
233.4477 USD |
Purchase |
1,715 |
233.1912 USD |
Purchase |
1,867 |
234.9495 USD |
Purchase |
2,008 |
233.0489 USD |
Purchase |
2,100 |
237.9069 USD |
Purchase |
2,155 |
232.4150 USD |
Purchase |
2,532 |
237.8722 USD |
Purchase |
2,718 |
233.0792 USD |
Purchase |
2,735 |
235.8429 USD |
Purchase |
2,769 |
233.2841 USD |
Purchase |
2,847 |
232.9973 USD |
Purchase |
2,914 |
237.8286 USD |
Purchase |
3,500 |
236.2974 USD |
Purchase |
4,546 |
237.8355 USD |
Purchase |
10,361 |
235.8861 USD |
Purchase |
11,271 |
237.1113 USD |
Purchase |
13,131 |
233.5120 USD |
Purchase |
13,981 |
234.7166 USD |
Purchase |
14,685 |
237.6848 USD |
Purchase |
17,087 |
235.1847 USD |
Purchase |
20,400 |
238.8491 USD |
Purchase |
23,561 |
234.9091 USD |
Purchase |
23,933 |
232.1900 USD |
Purchase |
26,743 |
235.3213 USD |
Purchase |
27,925 |
235.2857 USD |
Purchase |
45,492 |
233.0185 USD |
Purchase |
60,000 |
238.9000 USD |
Purchase |
65,527 |
233.0293 USD |
Purchase |
170,439 |
233.5715 USD |
Sale |
1 |
232.0400 USD |
Sale |
2 |
234.7700 USD |
Sale |
5 |
232.8700 USD |
Sale |
5 |
234.1170 USD |
Sale |
19 |
233.0400 USD |
Sale |
21 |
233.3100 USD |
Sale |
29 |
234.8648 USD |
Sale |
65 |
233.1300 USD |
Sale |
67 |
234.9476 USD |
Sale |
72 |
234.0100 USD |
Sale |
100 |
232.7300 USD |
Sale |
100 |
232.5640 USD |
Sale |
100 |
233.4500 USD |
Sale |
100 |
233.2400 USD |
Sale |
200 |
233.2350 USD |
Sale |
200 |
236.2737 USD |
Sale |
210 |
235.5238 USD |
Sale |
267 |
235.9906 USD |
Sale |
300 |
237.1400 USD |
Sale |
323 |
232.7748 USD |
Sale |
327 |
232.8632 USD |
Sale |
440 |
233.8225 USD |
Sale |
565 |
232.8565 USD |
Sale |
638 |
233.3751 USD |
Sale |
680 |
234.0230 USD |
Sale |
700 |
233.0692 USD |
Sale |
1,144 |
232.0000 USD |
Sale |
1,555 |
236.1741 USD |
Sale |
1,600 |
233.1493 USD |
Sale |
1,801 |
233.2633 USD |
Sale |
2,030 |
233.0833 USD |
Sale |
2,155 |
232.4150 USD |
Sale |
2,155 |
232.4151 USD |
Sale |
2,250 |
233.2853 USD |
Sale |
2,727 |
233.0070 USD |
Sale |
2,809 |
233.7694 USD |
Sale |
3,048 |
237.4035 USD |
Sale |
3,049 |
233.9488 USD |
Sale |
3,400 |
232.9185 USD |
Sale |
4,637 |
233.3044 USD |
Sale |
5,066 |
233.2121 USD |
Sale |
6,297 |
232.4064 USD |
Sale |
6,783 |
232.1900 USD |
Sale |
7,626 |
233.7378 USD |
Sale |
7,696 |
233.0705 USD |
Sale |
9,098 |
233.4150 USD |
Sale |
9,847 |
233.0235 USD |
Sale |
9,921 |
232.1907 USD |
Sale |
9,997 |
234.9061 USD |
Sale |
10,745 |
233.2703 USD |
Sale |
13,588 |
234.7720 USD |
Sale |
14,045 |
235.5625 USD |
Sale |
16,488 |
233.4763 USD |
Sale |
16,500 |
232.8718 USD |
Sale |
25,180 |
235.2434 USD |
Sale |
31,428 |
236.2032 USD |
Sale |
35,333 |
233.4434 USD |
Sale |
39,540 |
234.0116 USD |
Sale |
41,940 |
237.5237 USD |
Sale |
70,990 |
233.0516 USD |
Sale |
80,000 |
238.9000 USD |
Sale |
87,093 |
233.7142 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 18 Jun 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Put Options |
Purchased |
-100 |
220.0000 |
American |
Jul 16, 2021 |
Call Options |
Purchased |
100 |
240.0000 |
American |
Jul 16, 2021 |
Call Options |
Purchased |
6,000 |
220.0000 |
American |
Jul 16, 2021 |
Put Options |
Purchased |
-6,000 |
200.0000 |
American |
Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.